CV Sciences (CVSI) Interest Coverage Ratio Growth (3y) (2014 - 2026)
CV Sciences (CVSI) Interest Coverage Ratio Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.86 Bn | 42.90 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.54 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.79 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.57 Bn | 22.77 Bn | 5.10 Bn | -3.69% |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn | 75.30% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -72.71% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | -2.64% |
| 8 | Elanco Animal Health | 11.71 Bn | 11.18 Bn | 798.00 Mn | 37.62% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | CV Sciences | 4.10 Mn | 3.84 Mn | 1.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 30.95% |
| Mar 31, 2026 | -29.62% |
| Mar 31, 2025 | 26.60% |
| Dec 31, 2024 | -770.99% |
| Sep 30, 2024 | 62.98% |
| Jun 30, 2024 | 35.13% |
| Mar 31, 2024 | -34.22% |
| Sep 30, 2023 | -45.44% |
| Jun 30, 2023 | -67.08% |
| Mar 31, 2023 | 134.17% |
| Mar 31, 2022 | -229.53% |
| Dec 31, 2021 | -26.00% |
| Sep 30, 2021 | -1,042.28% |
| Jun 30, 2021 | -324.19% |
| Mar 31, 2021 | -100.19% |
| Sep 30, 2020 | 48.46% |
| Jun 30, 2020 | 12.40% |
| Mar 31, 2020 | 60.11% |
| Sep 30, 2019 | 77.09% |
| Jun 30, 2019 | 26.02% |